Minnesota Certified Medical Cannabis Consultant Training Program
$895
If you are a dispensary, medical group, or company interested in a multi-seat pricing discount, please call 844.411.0500 or email help@medicalmarijuana411.com. We understand training can be expensive and want to create a program that meets your needs.
Course Overview
Start right away! No wait times! 100% Online!!
Enroll now to receive a link to start the MM411 OCM APPROVED Minnesota Certified Medical Cannabis Consultant (CMCC) Training Program.
Why choose MM411
-
Self Paced – True Adult Learning – NOT ZOOM – Meets the OCM time based on competency
-
Best value: 48% less expensive than the other programs
-
Multi-Seat Purchase Discounts Available – please contact us at 844.411.0500
-
Permanent Learner Dashboard (versus 90 day window for accessibility)
-
Learn on your schedule: Fully asynchronous, online content lets learners start immediately and complete training without travel or time away from work.
-
Scalable for employers: Train single hires or entire teams without scheduling constraints or per‑session instructor costs.
-
Deeper curriculum: Stronger competency, case practice, and clinical readiness.
-
AMA, and other Accredited Courses for ACCME CE Credits (Physician, Pharmacist, and Nurses)
-
Dr. Ethan Russo Masters Level Certificate of Medical Cannabis Therapeutics and Pharmacology Programs
MM411 — Certified Medical Cannabis Consultant (CMCC) Training OCM‑Certified • 30 Hours • Fully Online • Start Immediately
Certify staff faster with zero travel or scheduling delays. MM411 delivers superior training, official OCM certification, and measurable ROI for clinics, medical professionals, dispensaries, and employers.
Why choose MM411
- Official: Certified by the Minnesota Office of Cannabis Management to deliver required CMCC training.
- Best value: 30 hours of comprehensive instruction ~48% less expensive than the other programs ($1,695)
- Deeper curriculum: Stronger competency, case practice, and clinical readiness.
- Learn on your schedule: Fully asynchronous, online content lets learners start immediately and complete training without travel or time away from work.
- Scalable for employers: Train single hires or entire teams without scheduling constraints or per‑session instructor costs.
What’s included
- Full 30‑hour CMCC curriculum meeting OCM requirements
- Interactive modules, case studies, and practical assessments
- Downloadable resources, educational graphics, patient counseling templates, and compliance checklists
- Online certificate upon completion for CMCC verification
- Dedicated learner support (email) and permanent student dashboard
Pricing & group discounts
Ready to enroll or set up a group purchase? Contact MM411 at 844.411.0500 or help@medicalmarijuana411.com.
MM411 Minnesota Office of Medical Cannabis (OCM) Certified Medical Cannabis Consultant (CMCC) Program is important for several reasons:
-
- Ensures compliance with Minnesota Office of Cannabis Management (OCM) legal guidelines for Certified Medical Cannabis Consultants (CMCC).
- Provides comprehensive knowledge on the safe handling, storage, and distribution of medical cannabis products in accordance with state regulations.
- Prepares individuals to operate within Minnesota’s strict medical cannabis laws, helping to prevent legal issues and sanctions.
- Demonstrates a strong commitment to professionalism and adherence to legal standards required by the OCM.
- Enhances credibility within the industry as a responsible and knowledgeable cannabis professional.
- Trains participants on proper customer interactions, including verifying identification, explaining product effects, dosing, and potential interactions.
- Emphasizes the importance of compliance, safety, and responsible practice in providing quality medical cannabis care
Reviews
Credibility and Standards
MM411 certifications are designed to ensure that individuals and organizations meet specific standards of knowledge and competence in the field of medical cannabis. These certifications help establish credibility among healthcare providers, industry workers (budtenders) patients, and the medical community.
Comprehensive Education
The certification process typically involves comprehensive educational programs that cover various aspects of medical cannabis, including its medical uses, legal regulations, dosing, how to medicate, and potential interactions with other medications. This enables certified individuals to provide accurate and informed guidance to patients.
Enhanced Patient Care
By obtaining an MM411 certification, healthcare professionals and budtenders can enhance their ability to support patients effectively. This certification provides them with the tools and knowledge necessary to help patients navigate their medical cannabis journey, leading to improved treatment outcomes and overall patient satisfaction.
Course Description & Syllabus
In 2014, Minnesota Governor Dayton signed the Minnesota Medical Marijuana Act (SF 2470) into law, which provides legal protections for patients with certain debilitating medical conditions who obtain a physician’s recommendation for the use of medical cannabis products. The law authorizes a regulatory program to oversee the distribution and manufacturing of permitted cannabis products, which may use liquid, pill or vaporized delivery methods, however the smoking of cannabis is prohibited. SF 2470 imposes no concentration limits on THC or CBD for these products, which offers maximum flexibility in designing medical cannabis treatments that can be tailored to treat a wide range of patient health conditions. Patient protections are strong in the 2014 law, though it does permit state collection of patient medical data for those patients who are recommended medical cannabis. With respect to patient access, the Minnesota Medical Marijuana Act allowed for eight dispensaries to be operated by private companies. Two companies are currently licensed to operate cultivation, manufacturing, distribution and retail facilities under the law.
In 2016, the state added intractable pain and PTSD to the list of qualifying conditions eligible for patient enrollment in the state system via HF 3142. This legislation also improved transportation laws for testing and disposal, and allowed pharmacists to video-conference with patients. In 2018, the Department of Health added sleep apnea, autism and Alzheimer’s to the list of qualifying conditions. The Minnesota Department of Corrections also moved to allow people on supervised release to use medical cannabis.
In 2019, the state expanded the number of legal medical retail facilities from 8 to 16. The Minnesota Department of Health also added chronic pain and macular degeneration to the list of conditions eligible for medical cannabis treatment. In 2020, under the state’s COVID emergency plans, Minnesota authorized medical cannabis businesses to continue operating, extended patient access through curbside pickup and home delivery, permitted telemedicine for physician evaluations, and extended existing enrollments. Source: Americans for Safe Access
There was hopeful addition for cannabis policy advocates in the 2022 legislature: The legislature and governor approved an omnibus bill (HF4065) that includes provisions to clearly legalize and to regulate hemp-derived edible and drinkable products infused with cannabinoids. It allows edibles with up to 5 grams of THC per serving and up to 50 grams per package.
Qualifying Conditions
- cancer, if the underlying condition or treatment produces one or more of the following: (i) severe or chronic pain; (ii) nausea or severe vomiting; oo (iii) cachexia or severe wasting;
- glaucoma;
- human immunodeficiency virus or acquired immune deficiency syndrome;
- Tourette’s syndrome;
- amyotrophic lateral sclerosis;
- seizures, including those characteristic of epilepsy;
- severe and persistent muscle spasms, including those characteristic of multiple sclerosis;
- Crohn’s disease;
- terminal illness, with a probable life expectancy of under one year, if the illness or its treatment produces one or more of the following:
- severe or chronic pain;
- nausea or severe vomiting;
- cachexia or severe wasting;
- PTSD;
- intractable pain; or
- any other medical condition or its treatment approved by the commissioner
- Scope & Purpose
- Vision
- Goals of CMCC training program
- Ensure patient safety and efficacy
- Maintain high standards of consultation
- Develop a robust and compliant training program
- Promote professionalism and accountability
- Downloadable Graphic – Goals of CMCC training program
- Your Role in a Licensed Medical Cannabis Retailer
- Downloadable Graphic – Certified Medical Cannabis Consultants – Roles and Responsibilities
- Downloadable Graphic – Certified Medical Cannabis Consultants – Cannot Give Medical Advice
- Minnesota Office of Cannabis Management. Medical Cannabis Consultant Training Program
If you are a dispensary, medical group, or company interested in a multi-seat pricing discount, please call 844.411.0500 or email help@medicalmarijuana411.com. We understand training can be expensive and want to create a program that meets your needs.
Module 1 - Introduction
- Scope & Purpose
- Vision
- Goals of CMCC training program
- Ensure patient safety and efficacy
- Maintain high standards of consultation
- Develop a robust and compliant training program
- Promote professionalism and accountability
- Downloadable Graphic – Goals of CMCC training program
- Your Role in a Licensed Medical Cannabis Retailer
- Downloadable Graphic – Certified Medical Cannabis Consultants – Roles and Responsibilities
- Downloadable Graphic – Certified Medical Cannabis Consultants – Cannot Give Medical Advice
- Minnesota Office of Cannabis Management. Medical Cannabis Consultant Training Program
Module 2 – US Legal
- Control Substances Act – Drug Schedule – 1972
- Current Legal States
- Industry Statistics
- Controlled Substances Act (CSA)(21 USCV 801, et seq.)
- Marijuana (cannabis) is a Schedule I drug – Definition
- The drug or other substance has a high potential for abuse.
- The drug or other substance has no currently accepted medical use in treatment in the United States.
- There is a lack of accepted safety for use of the drug or other substance under medical supervision.
- Downloadable Graphic – Schedule I Drugs
- Cannabaceae – Definition
- Safe Banking Act
- U.S. Pat. No. 6,630,507
- Odgen Memo
- Cole Memo
- Wilkenson Memo
- Rohrabacher-Blumenauer Amendment
- Conant v. Walters (309 F.3d 629)
- Downloadable Graphic – What Medical Professionals Can Legally Provide To Their Patients
- Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research – FDA Position
- Downloadable PDF – Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
- Video – FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds
- Taxes
- Affirmative Defense
- Bankruptcy
- Employment Law
- Financial Crimes Enforcement Network (FinCEN)
Module 3 - Minnesota Legal
- Office of Cannabis Management (OCM)
- Minnesota legalized adult recreational cannabis use with the passage of 2023 House File (HF) 100 – April 2023
- Office of Medical Cannabis (OMC) moved from the Minnesota Department of Health (MDH) to become the Division of Medical Cannabis (DMC) within OCM – July 2024
- OCM will transition from enforcing Minnesota Statutes, chapter 152, and Minnesota Rules, chapter 4770, to enforcing Minnesota Statutes, chapter 342, and Minnesota Rules, chapter 9810 – December 2025
- Manufactures
- Tribal medical cannabis program manufacturer
- Where You Can Consume
- Where You Cannot Consume
- Other Legal Methods
- Qualifying Medical Conditions
- Alzheimer’s disease
- Amyotrophic lateral sclerosis (ALS)
- Autism spectrum disorder
- Cancer*
- Chronic motor or vocal tic disorder
- Chronic pain
- Glaucoma
- HIV/AIDS
- Inflammatory bowel disease, including Crohn’s disease
- Intractable pain
- Irritable bowel syndrome
- Obsessive-compulsive disorder
- Obstructive sleep apnea
- Post-traumatic stress disorder
- Seizures
- Severe and persistent muscle spasms
- Sickle cell disease
- Terminal illness with life expectancy of under one year*
- Tourette’s syndrome
- Any other condition or its treatment approved by the commissioner (subject tolegislative oversight)
* Illness or treatment must produce one or more of the following:
(1) severe or chronic pain;
(2) nausea or severe vomiting; or
(3) cachexia or severe wasting.
- Certified Medical Cannabis Consultant Program (CMCC)
- Statutory references
- Minnesota Statutes, section 342.51, subdivision 1: Endorsement; authorized actions.
- Minnesota Statutes, section 342.51, subdivision 2: Distribution Requirements.
- Minnesota Statutes, section 342.51, subdivision 3: Final approval for distribution of medical cannabis flower and medical cannabinoid products.
- Minnesota Rules, part 9810.2502, subpart 5: Patient Consultation.
- Minnesota Rules, part 9810.4100: Medical Cannabis Consultant Program
- Remote Consultation
- Certified Medical Cannabis Consultant (CMCC) – Verification for Purchase
- Patient Identification (ID)
- Patient Certification
- Patient Registry
- Required Documents – Approved ID
- Cannabis Product Labeling Requirements
- Product Name and Type: Clear identification of the product’s name and form (e.g., tincture, edible, flower).
- Ingredients: A list of ingredients, especially for edibles and infused products.
- Cannabinoid Content: Accurate labeling of active cannabinoid levels, including THC and CBD concentrations, in milligrams.
- Net Weight or Volume: The total weight or volume of the product.
- Manufacturing Details: Name and contact information of the licensed manufacturer or distributor.
- Batch or Lot Number: For traceability and quality control purposes.
- Expiration Date: If applicable, indicating shelf life or expiration.
- Warning Statements: Mandatory health warnings as specified by Minnesota regulations, including warnings about psychoactive effects, age restrictions, and safe use.
- Child-Resistant Packaging: Ensuring the container is child-resistant where applicable.
- Storage Instructions: Any necessary storage precautions.
Module 4 – The Endocannabinoid System (ECS)
- ECS Discovery and Definition
- Video – Dr Jake Felice discusses the ECS, terpenes, dosing, and pain management
- Video – Visualization of the endocannabinoid signaling system
- ECS and the body’s maintenance of homeostasis
- Downloadable Graphic – The Human Body’s Endocannabinoid System
- Video – Dr Jake Felice discusses the ECS, the largest receptor system in the human body
- ECS and Neurotransmitter Systems (ie dopamine, serotonin, histamine)
- Isolation Cannabidiol, or CBD, and the psychoactive molecule delta-9-tetrahydrocannabinol, or THC – Raphael Mechoulam 1964
- Video – Raphael Mechoulam – The Scientist
- Dr. Allyn Howlett – Discovery of the ECS – 1988
- Death by Drug – Why There Have Been No Deaths by Cannabis
- Cannabis Dependence
- Raphael Mechoulam 1992 – Discovery of Anandamide and 2-Arachidonoylglycerol
- CB1 and CB2 Receptors
- Downloadable Graphic – Location of CB1 and CB2 Receptors
- CB1 Receptors and The Brain
- CBD modulates the effects of THC
- Biased Signaling
- CB2 Receptors
- Location & Function
- Retrograde Inhibition
- Lack of Training of the ECS in Medical Schools
- Downloadable Graphic – Health Benefits of Cannabis
- ECS and Human Thriving Behavior
- Video – Dr Melanie Drive – Thriving Behavior Study
Module 5 – Cannabinoids and Terpenes
-
- Endogenous and Exogenous cannabinoids and how they interact with the Endocannabinoid System (ECS)
- The Cannabis plant contains over 600 chemical compounds
- Major Cannabinoids
- THC
- CBD
- Minor Cannabinoids – more than 113 – isolate the more prominent ones
- Cannabigerol (CBG)
- Cannabichromenic acid (CBC)
- Cannabinol (CBN)
- Tetrahydrocannabivarinic acid (THCVA)
- Downloadable Graphic – Cannabinoid Guide
- Terpenes
- Downloadable Graphic – Terpene Chart
- Video – Dr Jake Felice discusses terpenes
- The Entourage Effect
- Downloadable PDF – Dr Ethan Russo – Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
- Downloadable PDF – Dr Ethan Russo – Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?
- Cannabis Tolerance
- Botanical vs Single Molecule Compounds
Module 6 – Getting Cannabinoids into the Bloodstream
-
- Inhalation, oral mucosal absorption, edibles, topicals, and others — plus the bioavailability, advantages and disadvantages of each
- Understanding options for patients
- Cannabinoid and Terpene Profiles
- Inhalation
- Activation Time
- Duration
- Bioavailability
- Advantages
- Disadvantages
- Vaporization
- Activation Time
- Duration
- Bioavailability
- Advantages
- Disadvantages
- Cannabis Flower vs Concentrates
- Activation Time
- Duration
- Bioavailability
- Advantages
- Disadvantages
- Different Types of Concentrates
- Extraction Methods
- Concentrates Using Solvents
- Solventless Concentrates
- Concentrates: Dabs, Shatter, Wax, Budder, BHO, EHO, PHO, Hash, Rosin, Distillate
- Activation Time
- Duration
- Bioavailability
- Advantages
- Disadvantages
- Edibles
- Activation Time
- Duration
- Bioavailability
- Advantages
- Disadvantages
- “Start Low, Go Slow”
- Downloadable Graphic – Know Your Edibles
- Oral Muscosal: Tinctures, Sprays, Sublingual Drops
- Activation Time
- Duration
- Bioavailability
- Advantages
- Disadvantages
- Topicals: Creams, Salves ,Roll-ons, Pain Patches
- Activation Time
- Duration
- Bioavailability
- Advantages
- Disadvantages
- Suppositories
- Activation Time
- Duration
- Bioavailability
- Advantages
- Disadvantages
- Downloadable Graphic – What Medical Professionals Can Legally Provide To Patients
- Role of the Dispensary and CMCCs
- Strain, Labels, Cost
- Downloadable Graphics – CMCC Roles and Responsibilities & What You Can and Cannot Do
Module 7 – Patient Centered Dosing
- Product Labels
- Downloadable Graphic – How CBD Cuts The Negative Effects of CBD
- Titration
- THC’s Most Common Side Effects
- Set and Setting
- Drug-Drug Interactions
- Relative Contradindications
- Pregnant and Nursing Mothers
- Youth Under 25
- Patients with Cardiac Conditions
- Patients with Psychiatric Diagnoses
- Immunocompromised Patients
- Biphasic Effect
- Basic Dosing Protocol
- Downloadable Graphic – Dosing Protocol
- Downloadable Graphic – Find Your CBD:THC Ratio
- Recommended Ratios for Certain Illnesses
- Inhalation
- Edibles
- Tinctures
- Topicals
Module 8 – Laboratory Testing
- How Testing Works
- Cannabinoid and Terpene Composition
- Potency
- Liquid Chromatography
- Contaminants: Pesticides, Fungi, and Mold
- Gray Mold and Powdery Mildew
- State to State Testing Programs
- How to Interpret a Test
- Measure of Potency of Cannabis
- Terpenes
- Certificate of Analysis
Module 9 – Clinical Practice
- NOTE: This module provides an overview of some of the illnesses that cannabis is being approved as a form of treatment, but it is important to know the list of approved conditions for Minnesota, covered in the Minnesota legal module. Additional conditions are covered for educational purposes only.
- Overall Efficacy and Use of This Botanical Medicine
- Downloadable Graphic – Know Your Cannabinoids
- Anxiety Disorders
- Proposed Mechanism
- Cancer
- Proposed Mechanism
- Video – Physician David Casarett was tired of hearing hype and half-truths around medical cannabis
- Epilepsy
- Proposed Mechanism
- Video – Dr. Jokubas Ziburkus “There is something you should know about epilepsy and cannabis”
- Video – Medical Marijuana: A Conversation with Dr. Sanjay Gupta
- Gastrointestinal Disorders
- Proposed Mechanism
- Glaucoma
- Proposed Mechanism
- Video – Medical Marijuana 411 talks to Elvy Musikka about her experience using marijuana for her glaucoma. Elvy is one of original seven patients that was accepted into the NIDA compassionate use program.
- HIV/AIDS/Wasting Syndrome
- Proposed Mechanism
- Video – Dr Donald Abrams talks to Medical Marijuana 411 about his experience with cannabis and his experience with HIV/AIDS patients using medical marijuana for symptoms.
- Migraine Headaches
- Proposed Mechanism
- Multiple Sclerosis (MS)
- Proposed Mechanism
- Downloadable Graphic – 2023 Cannabis and MS – The Way Forward
- FDA Approved Cannabinoid Drugs
- Dronabinol (Marinol®)
- Nabilone (Cesamet®)
- Downloadable PDF – Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology.
- Neurodegenerative disorders (NDs)
- NDs include Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Parkinson’s disease.
- Proposed Mechanism
- Neuropathy
- Proposed Mechanism
- Pain
- Video – Dr Mark Ware, talks to Medical Marijuana 411 about pain, pain management and how cannabis can have a positive impact on those inflicted with pain issues.
- Proposed Mechanism
- Palliative Care
- Downloadable PDF – Use of Medical Cannabis for Palliative Care – A Systematic Review
- Downloadable PDF – Cannabis Use In Palliative Care – History, Legality, and Implications in Practice
- Proposed Mechanism
- Parkinson’s Disease (PD)
- Proposed Mechanism
- Video – See the effects of cannabis first hand, unedited, on Parkinson’s tremor dyskinesia, and voice. This clip is from the feature documentary “Ride with Larry” and shows retired police captain Larry trying medical marijuana for the first time.
- Post Traumatic Stress Disorder PTSD
- Proposed Mechanism
- Video – Dr. Sue Sisley talks to Medical Marijuana 411 about her research with veterans and those afflicted with PTSD. She is one of the leading researcher professionals documenting patient use of medical marijuana for symptoms.
- Sleep
- Downloadable Graphic – Cannabinoid Guide
- Proposed Mechanism
- Traumatic Brain Injury TBI
- Proposed Mechanism
- Women’s Health
- Endometriosis
- Premenstrual Syndrome and Premenstrual Dysphoric Disorder
- Menopause
- Proposed Mechanism
Module 10 – Storage and Handling of Cannabis
- Cannabis is a Delicate Plant
- Trichomes
- Flowers and Extracts
- Containers
- Light
- Temperature
- Glass
- Exposure to Air
- Soft Plastics – No-No
- Vacuum Packing
- Storing tinctures, medical edibles, and concentrates
- Refrigeration
- Cannabis Flower
- Ability to Smell Product Before Purchase in Minnesota
- Avoid Rough Handling – Trichomes are Delicate
Module 11 – Cannabis and Opioids
- Opioid Use Disorder
- Dependence
- Global Patterns
- Minnesota Opioid Deaths
- Downloadable Graphic – In chronic pain patients currently prescribed opioids, does adjunctive therapy with medical marijuana result in reduced opioid dosages?
- Pain
- Comparative Pain Scale
- Addictive Potential of Opioids
- Downloadable Graphic – Underlying Principles
- Downloadable PDF – prescribing naloxone to all patients at risk for opioid complications
- Caused of Death by Drug
- Cannabinoids and Opioids
- Downloadable PDF – Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain
- Downloadable PDF – Emerging Evidence for Cannabis’ Role in Opioid Use Disorder
- Downloadable PDF – Cannabis: A Promising Option for the Opioid Crisis
- Cannabis and NSAIDs
Module 12 – Side Effects Abuse and Misuse
- Cannabis Use Disorder
- Short Term Effects
- Long Term Effects
- Physical Effects
- Breathing Problems
- Increased Heart Rate
- Problems with Child Development
- Cannabinoid Hyperemesis Syndrome (CHS)
- Mental Effects
- Stroke
- Important Information – What to Avoid
- Operating Machinery and Driving
- Alcohol
- Cannabis Overconsumption
-
Cannabis Tolerance
Lucas L. –
Overall a very well done course. I had previous knowledge from personal learning and experience over the years so it helped me refresh on what I already know and added a lot to what I can learn. Thank you very much for putting this together. 10/10!
alexander d. –
Loved taking this course..tons of knowledge and practical application methods to take from this.
James B. –
I had a blast with the course and will be re visiting it to ensure I retain all the information covered.
Markel B. –
Fantastic customer service and an incredible course. Look no further and sign up with MM411! They also gave us a great discount for our team!!! Highly recommend!!!
Adam S. –
My experience was great, the course was smooth and the content was clear.
Patricia S. –
Most of the material was review for me. I took a cannabis certification course through INCA in 2023. I do feel like this program would be great for integrative, holistic, and lifestyle medicine practitioners. Nurses as well as pharmacists are best suited for this role. Retired or not.
Elias R. –
Great course!
Christine D. –
Excellent course!
Robert B. –
_
Jesse L. –
some of the linked videos are privated, making them inaccessible.
MaryAnn N. –
_
Dante S. –
_
Zachary K. –
_
Gina G. –
_
Abbas B. –
_
Teresa K. –
_
Tarah P. –
_
Joseph A. –
_
Stefanie P. –
_
Trenton M. –
_
Troy Z. –
_
Carey T. –
_
Robert W. –
_
Jennifer S. –
_
Mark E. –
_
Audra M. –
_
Only logged in customers who have purchased this product may leave a review.